Calcifediol could be recommended in patients with obesity, malabsorption syndromes, CYP2R1 dysfunction, or in situations in which a quick, rapid achievement of vitamin D sufficiency is desirable. This evidence concerns the gene CYP2R1 and malabsorption syndrome.